Pharma Uniphar profits climb 27 per cent on the back of booming supply chain and pharma growthThe pharma company reported over 34 per cent growth in its supply chain, retail and pharma wings, with more modest growth in its medtech division
Markets Analysis: How Irish company directors are outliers when it comes to having skin in the gameJust four listed Irish companies have a board where every member has a stake in the business
Markets Iseq Index trades lower as shares in healthcare and tourism exposed companies fallShares in Malin Corporation, Uniphar, Dalata Hotels and Irish Continental all traded lower on Tuesday morning
Profit & Loss Profit & Loss: McCauley’s Pharmacy racks up €2.8m loss while turnover soars at Circle K IrelandRevealing who is up and who is down as we go inside the world of Irish businesses
Markets Markets Wrap: US job openings unexpectedly rise; Uniphar extends Iseq gainsHotter-than-estimated reading on the labour market has damped hopes of a rate cut a day before the Federal Reserve releases its decision
Markets Market Wrap: Eurozone dodges recession; Uniphar rises on resultsLatest figures show the 20-nation eurozone has narrowly avoided recession as gross domestic product came in flat in the final quarter of 2023
Companies Uniphar plots further M&A deals and reiterates medium-term target to hit €200m in profitsThe listed healthcare group said it achieved steady growth in 2023 and is forecasting double-digit expansion of its new pharma division this year
Markets Markets Wrap: Pharma gains push Iseq into the greenFlutter’s shares remained unchanged from the time markets closed on Friday as the firm prepares for its last day of trade in Dublin
Health Swedbank Robur takes €20 million in Irish healthcare company UnipharUniphar’s share price has fallen from its high of nearly €5 at the start of 2022 to its current price of just below €2.40
Health Uniphar first-half revenues top €1bnHealthcare group said it had achieved its target of doubling 2018 pro forma adjusted earnings
Markets Lunchtime Markets Latest: ISEQ dips as Glenveagh and Flutter shares sinkDublin stock exchange remains strong after reaching highs not seen since Celtic Tiger last week
Health Irish-listed healthcare firm Uniphar sees organic profits soar by 5%Group accounts for over one fifth of the Irish retail pharmacy market
Companies Uniphar reports earnings of €98 million for 2022Irish-listed healthcare group is active in Europe, North America, Asia-Pacific and the Middle East and North Africa
Investing Man Group takes short bet against Uniphar Uniphar’s share price has fallen from its high of nearly €5 at the start of 2022 to its current price of around €3.30
Competition Uniphar scraps NaviCorp acquisition after competition watchdog blocks deal Pharmacy solutions company has announced a number of acquisitions over recent months but this one has been prohibited by the CCPC
Healthcare Uniphar acquires Dutch pharmaceutical company for €75mBModesto focuses on the distribution of medicines, clinical trial services, market authorisation holder and medical device distribution
Companies Uniphar agrees deal to buy McCauley Pharmacy GroupPurchase adds 37 retail pharmacies to Uniphar Group
Uniphar reports €965m in revenue despite post-Brexit environment ‘risks’The group credited 2021 acquisitions as pivotal to bolstering its high-performance commercial and clinical division
Stocking up in 2021: the picks to watch this yearFrom beleaguered Datalex to booming Kerry Group, keep an eye on these companies’ market performances in the coming year